/Investor DB

Kern Capital, LLC

Family office

Larkspur · Seed–Late Stage · 1 people tracked

Find your way into Kern Capital, LLC

Each arrow is one introduction. Sign up to fill in the first one.

503 people can intro you to Jay

Ask David Sacks to introduce you to Jay Kern

You →David · together at University of Chicago Law School →Jay

Sign up to find every way you can get introduced to Kern Capital, LLC

  • Your email: who you already know at Kern Capital, LLC, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Kern Capital, LLC team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Kern Capital invests in a diversified range of companies from new ventures to established, profitable businesses across many industries, with an emphasis on life sciences. It makes concentrated investments of $5 to $15 million in only a few companies per year and partners with strong management teams for the long term, typically taking board seats without involvement in daily operations. The firm adopts a long-term liquidity approach that is not tied to any single exit path, remaining opportunistic about returning capital via M&A, IPO, recapitalization, dividend, or otherwise. Its capital comes from high-net-worth individuals, family offices, and foundations, and principals typically serve as the largest personal investors in each portfolio company.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Late Stage
Check
$5M – $15M
HQ
Larkspur, California, US
Leads rounds
Leads
Instruments
Equity
Founded
2020
Tracked investments
21
Acquisitions
3

Team · 1 people

from public directories

What they invest in

from 8 of 21 portfolio companies

Biotech ×5Healthtech ×3SaaS ×2Consumer ×1Data & Infrastructure ×1Enterprise Software ×1Fintech ×1Gaming ×1

HQs:United States×8

Investments · 21 tracked

founders shown can be your intro path

By year:2025 · 12024 · 22022 · 12019 · 15 dated

AIdentifiedaidentified.comin𝕏Jun 2024

Aidentified provides wealth network intelligence software that searches 300M+ consumer and professional profiles, maps a user's existing connections to identify introduction paths to prospects, and monitors wealth events (such as IPOs, acquisitions, and property transactions) to signal outreach timing.

Data & InfrastructureFintechSales TechConcord, US

Darr Aley(Director)inG. Thomas Aley(Director)Juliana Spofford(Executive Officer)inThomas C. Rauker(Executive Officer, Director)

BoardMatthew Conway(Director)John Kern, Jr.(Director)

PartnerJay Kern· solo GP

GPN Vaccinesgpnvaccines.comJun 2024 · $18M

GPN Vaccines is a clinical-stage company developing vaccines against bacterial pathogens, including a vaccine to prevent pneumococcal disease.

BiotechHealthtechNew York, US

Timothy Hirst(Executive Officer, Director)James Selkirk(Executive Officer)in

Co-investorsForepont Capital PartnersShearwater Capital

Latigo Biolatigobio.comJan 2025

Latigo Biotherapeutics is a clinical-stage biopharmaceutical company developing non-opioid pain medicines designed to stop pain transmission without addiction risk.

BiotechHealthtechMedical DevicesThousand Oaks, US

Nima Farzan(Executive Officer, Director)Tim Lugo(Executive Officer)

BoardBeth Seidenberg(Director)inJim Tananbaum(Director)inDeborah Palestrant(Director)inKevin Raidy(Director)

PartnerJay Kern· solo GP

Co-investors5AM VenturesAccess BiotechnologyAscenta CapitalForesite CapitalSanofi VenturesWestlake Village BioPartners

Lottery Nowlottery-now.comNov 2019

Mido Lotto is a mobile app that acts as a digital courier for buying official state lottery tickets from licensed retailers, letting users order tickets, join group pools, and collect smaller winnings into an in-app wallet.

ConsumerGamingSaaSSan Francisco, US

Kevin Kramer(Executive Officer)

PartnerJay Kern· solo GP

Co-investorsSand Hill Angels

ProServiceproservice.comin

ProService Hawaii provides payroll, employee benefits, HR, and compliance solutions to employers in Hawaii.

Enterprise SoftwareHR TechSaaSKailua-Kona, US

Ben Godsey(President & CEO)in

PartnerJay Kern· solo GP

Co-investorsFFL PartnersSilver Lake Partners

Riboscienceriboscience.com

Ribo Science is a biopharmaceutical company focused on discovering and developing novel ribose-based molecules for treating human cancers and viral diseases.

BiotechHealthtech

PartnerJay Kern· solo GP

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

4J TherapeuticsApton BiosystemsArcadia CommunicationsConcentric AnalgesicsDiscoviaInvestCloudIonetixISIPallet Logistics of AmericaPGDxProvider SynergiesReata PharmaceuticalsShopatron Inc.Tab ProductsTech Lighting

Exits · 3

3 acquisitions

Apton Biosystemsacq. by Pacific BiosciencesPGDxacq. by LabcorpReata Pharmaceuticalsacq. by Biogen

Portfolio news

latest coverage across their companies
Riboscience Raises $146.8 | Signalbase

Riboscience · trysignalbase.com · May 26, 2026

Frequently asked questions

How many investments has Kern Capital, LLC made?
Kern Capital, LLC has 21 tracked investments, 3 of which have exited, including 1 dated in the last 24 months.
What stage does Kern Capital, LLC invest at?
Kern Capital, LLC invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What is Kern Capital, LLC's typical check size?
Kern Capital, LLC typically writes checks of $5M – $15M.
What sectors does Kern Capital, LLC focus on?
Kern Capital, LLC focuses on Advanced Manufacturing, Biotech, Fintech, Healthtech, Medical Devices, SaaS, Sector Agnostic.
Where is Kern Capital, LLC located?
Kern Capital, LLC is headquartered in Larkspur, US.
Does Kern Capital, LLC lead rounds?
Yes, Kern Capital, LLC leads investment rounds.
Who does Kern Capital, LLC co-invest with?
Kern Capital, LLC most often shares deals with 5AM Ventures, Foresite Capital, Samsung Catalyst Fund, among 18 tracked co-investors.

Similar investors

Featured in lists